Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

296
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
296
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

423
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
423
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

620
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
620
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

453
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
453
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

574
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
574
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

637
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
637

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity].

Terapevticheskii arkhiv·2026
Same author

[A new paradigm of the pathogenesis of primary sclerosing cholangitis associated with ulcerative colitis: microbiota and system intestine-liver. A review].

Terapevticheskii arkhiv·2026
Same author

[Radiation-induced intestinal injury].

Terapevticheskii arkhiv·2025
Same author

[Prevention of venous thromboembolic complications in patients with ulcerative colitis].

Terapevticheskii arkhiv·2025
Same author

[Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis].

Terapevticheskii arkhiv·2025
Same author

[Chronic small bowel obstruction in a patient with post-radiation enteropathy. Case report].

Terapevticheskii arkhiv·2025

Related Experiment Video

Updated: Nov 12, 2025

A Mouse Model of Intestinal Partial Obstruction
07:33

A Mouse Model of Intestinal Partial Obstruction

Published on: March 5, 2018

22.0K

[Chronic intestinal pseudo-obstruction].

A I Parfenov1, L M Krums1, S V Bykova1

  • 1Loginov Moscow Clinical Scientific Center.

Terapevticheskii Arkhiv
|March 15, 2021
PubMed
Summary
This summary is machine-generated.

Chronic intestinal pseudo-obstruction is a rare motility disorder mimicking mechanical blockage. Treatment involves nutritional support, prokinetic drugs, and decompression, with surgery or transplantation for severe cases.

Keywords:
bacterial insemination syndromechronic intestinal pseudo-obstructionintestinal decompressionintestinal transplaniationmalabsorptionneuromyopathyparenteral nutritionprokinetics

More Related Videos

Postoperative Ileus Murine Model
04:26

Postoperative Ileus Murine Model

Published on: July 12, 2024

1.0K
Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.5K

Related Experiment Videos

Last Updated: Nov 12, 2025

A Mouse Model of Intestinal Partial Obstruction
07:33

A Mouse Model of Intestinal Partial Obstruction

Published on: March 5, 2018

22.0K
Postoperative Ileus Murine Model
04:26

Postoperative Ileus Murine Model

Published on: July 12, 2024

1.0K
Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
09:44

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

22.5K

Area of Science:

  • Gastroenterology
  • Digestive System Disorders

Background:

  • Chronic intestinal pseudo-obstruction (CIPO) is a rare gastrointestinal motility disorder.
  • It presents symptoms similar to mechanical obstruction but lacks a physical blockage.
  • CIPO arises from impaired smooth muscle or nervous system function in the GI tract.

Purpose of the Study:

  • To summarize the pathophysiology, symptoms, and management of chronic intestinal pseudo-obstruction.
  • To highlight the impact of peristaltic dysfunction on nutrient absorption and overall health.
  • To outline current and advanced treatment strategies for CIPO.

Main Methods:

  • Review of existing literature on chronic intestinal pseudo-obstruction.
  • Analysis of the etiological factors, including smooth muscle and neural dysfunction.
  • Synthesis of information on clinical manifestations and diagnostic considerations.

Main Results:

  • Common symptoms include constipation, abdominal pain, nausea, vomiting, and bloating.
  • Peristaltic dysfunction leads to small intestinal dilation and bacterial overgrowth (small intestinal bacterial overgrowth syndrome).
  • This can result in malabsorption, malnutrition, and cachexia.

Conclusions:

  • Effective management requires nutritional support, prokinetic agents, and antimicrobial therapy.
  • Intestinal decompression is a key intervention.
  • Refractory cases may necessitate surgical resection or intestinal transplantation.